Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)
●International Lymphoma Radiation Oncology Group (ILROG): Guidelines for the optimal use of imaging in radiation therapy for lymphoma (2019)
●Rare Cancer Network (RCN): Primary extranodal lymphoma of the glands – Literature review and options for best practice (2019)
●Revised adult T-cell leukemia-lymphoma international consensus meeting report (2019)
●International working group consensus response evaluation criteria in lymphoma (2017)
●Report of the 6th international workshop on PET in lymphoma (2017)
●World Health Organization (WHO): Classification of lymphoid neoplasms, revision (2016)
●International Conference on Malignant Lymphomas (ICML): Consensus on the role of imaging in the staging and response assessment of lymphoma (2014)
●Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma − The Lugano classification (2014)
Canada
●Choosing Wisely Canada: Don't request a fine-needle aspirate (FNA) for the evaluation of suspected lymphoma (updated 2020)
●Cancer Care Ontario (CCO): Consensus pathology recommendations for complex malignant hematology (2016)
●CCO: The clinical utility of positron emission tomography in the diagnosis, staging, and clinical management of patients with lymphoma – Recommendation report (2015)
United States
●American Radium Society (ARS): Executive summary of appropriate use criteria on primary mediastinal B cell lymphoma in the positron-emission tomography era (2021)
●American Society for Clinical Pathology (ASCP) and College of American Pathologists (CAP): Guideline on the laboratory workup of lymphoma in adults (2021)
●Best practices guideline for the pathologic diagnosis of breast implant–associated anaplastic large-cell lymphoma (2020)
●Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) – An overview of presentation and pathogenesis and guidelines for pathological diagnosis and management (2019)
Europe
●European Society for Medical Oncology (ESMO): Newly diagnosed and relapsed follicular lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2021)
●ESMO: Marginal zone lymphomas – Clinical practice guidelines for diagnosis, treatment and follow-up (2020)
●ESMO: Consensus conference on malignant lymphoma − General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma (2018)
●ESMO: Consensus conference on malignant lymphoma – Management of 'ultra-high-risk' patients (2018)
●ESMO: Hodgkin lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2018)
●ESMO: Primary cutaneous lymphomas – Clinical practice guidelines for diagnosis, treatment and follow-up (2018)
●European Organisation for Research and Treatment of Cancer (EORTC): Recommendations on blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry (2018)
●ESMO: Newly diagnosed and relapsed mantle cell lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2017)
●ESMO: Consensus conference on malignant lymphoma – General perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia (2016)
●ESMO: Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2016)
●ESMO: Diffuse large B-cell lymphoma (DLBCL) – Clinical practice guidelines for diagnosis, treatment and follow-up (2015)
●ESMO: Peripheral T-cell lymphomas – Clinical practice guidelines for diagnosis, treatment and follow-up (2015)
●European Association for Neuro-Oncology (EANO): Guidelines for the diagnosis and treatment of primary CNS lymphoma in immunocompetent patients (2015)
United Kingdom
●Medicines and Healthcare Products Regulatory Agency (MHRA): UK guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) (2021)
●British Society for Haematology (BSH): Guideline for the investigation and management of follicular lymphoma (2020)
●BSH: Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma (2019)
●BSH: Good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma (2018)
●British Committee for Standards in Haematology (BCSH): Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma (2016)
●National Institute for Health and Care Excellence (NICE): Guideline on non-Hodgkin's lymphoma − Diagnosis and management (2016)
●BCSH: Guidelines for the first line management of classical Hodgkin lymphoma (2014)
India
●Indian Council of Medical Research (ICMR): Consensus document for management of pediatric lymphomas and solid tumors (2017)
●ICMR: Consensus document for management of non Hodgkin's lymphoma (high grade) (2016)
Japan
●[In Japanese] Japanese Dermatological Association (JDA): Cutaneous malignant tumor – Cutaneous lymphoma clinical practice guidelines, 3rd edition (2020)
●[In Japanese] Japanese Society of Pediatric Hematology/Oncology (JSPHO): A practical guideline for pediatric leukemia and lymphoma, 3rd edition (2016)
